This strategy forms the basis for our approach between 2025 and 2030. Throughout this period, we will work with researchers, health professionals and policy makers, and across the commercial, ...

Why context matters in health testing: beyond the “self-test” kit Whether you’re checking your thyroid levels, vitamin deficiencies, or hormone balance, what direct-to-consumer “tests” don’t tell you ...

Unpacking the rhetoric of personalisation What does it take to personalise a health system? Two models have come to dominate responses to this challenge. One – commonly referred to as ‘ personalised ...

A consultation by the UK Medicines and Healthcare products Regulatory Agency indicates a new direction for public and patient involvement.

A set of consensus statements on the use of biomarkers in cancer research and treatment were released this month. We discuss what these mean.

It’s been quite a wait, but the much-anticipated National Genomics Healthcare Strategy, has now landed. GENOME UK: The future of healthcare sets out plans to use genomics to drive improvements in ...

In this blog, I will delve into some of the growing acceptance in healthcare to innovative approaches in various countries, and how a database will facilitate analysis and interpretation for all. The ...

It is no secret that the AI regulatory landscape has experienced monumental shifts in the last six months. Rhetoric that views regulation as a barrier to AI innovation and the cross-sectoral ...

We are getting closer to a world where the debilitating pain and complications of sickle cell disease are a thing of the past. For the 17,500 people in the UK living with this genetic condition, this ...

The rapid development, approval and roll out of multiple vaccines against SARS-CoV-2, the virus that causes COVID-19, is an impressive achievement for science and healthcare. The virus genome was ...

Colin Mitchell sets out why our work to clarify the impact of the GDPR on the use of genomic data is so necessary. The work is funded by the Information Commissioner's Office ...

The UK government has launched a new alliance to sequence the genomes of SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Backed by a £20 million investment, the COVID-19 Genomics ...